Riskpilot← Back to searchSign inGet full accessDr. Maged AB
ABActiveOrg 5568873490Hundhamravägen 164Medical specialists activities · NACE 8622Est. 20121 employees
Revenue 2025
SEK 224K
+9% vs 2024
EBITDA margin
-4.3%
+85% vs 2024
Equity ratio
87.3%
Financial strength
Net profit 2025
SEK 649K
+561% vs 2024
| Revenue | SEK 224K | +9% |
| EBITDA | SEK -10K | +85% |
| Net profit | SEK 649K | +561% |
| Total assets | SEK 17,7M | +10% |
| Equity | SEK 15,5M | +3% |
| Employees | 1 | — |
Legal name
Dr. Maged AB
Org number
5568873490
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
12 mars 2012
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva medicinsk konsultation, samt läkarvård och därmed förenlig verksamhet.
Address
Hundhamravägen 164
Email
fn_785@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 807 | 2 155 | 984 | 206 | 224 |
| Staff expenses | — | −192 | −88 | −77 | −81 |
| EBITDA | 1 074 | 1 772 | 682 | −65 | −10 |
| Depreciation & amort. | −103 | −43 | −47 | −47 | −159 |
| EBIT | 971 | 1 729 | 635 | −112 | −169 |
| Net financials | 5 064 | 299 | 442 | 623 | 1 528 |
| Profit before tax | 5 485 | 1 528 | 527 | −141 | 649 |
| Tax | −165 | −323 | −116 | — | — |
| Net profit | 5 320 | 1 205 | 411 | −141 | 649 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 15 381 | 16 595 | 16 507 | 16 077 | 17 742 |
| Equity | 14 144 | 15 164 | 15 389 | 15 053 | 15 497 |
| Long-term debt | 1 031 | 1 208 | 1 082 | 1 009 | 2 220 |
| Short-term debt | 207 | 223 | 36 | 15 | 25 |
| Total debt | 1 238 | 1 431 | 1 118 | 1 024 | 2 245 |
EBITDA margin
-4.3%
This company
15.8%
Market median
-127% vs market
20212025
Equity ratio
87.3%
This company
38.2%
Market median
+129% vs market
20212025
Return on equity
4.2%
This company
18.4%
Market median
-77% vs market
20212025
Net profit margin
289.3%
This company
8.1%
Market median
+3472% vs market
20212025
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20212025
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Dr. Maged AB 
Maraya Fastighet ABBoard members of Dr. Maged AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marina Samir Yagoub | Deputy Board Member | 0 companies |
| Maged Youssef | Board of Directors | 0 companies |
| Steven Youssef | Deputy Board Member | 0 companies |